A simple prostate test could end misery of painful biopsies

SGMC Hosts Prostate Cancer Screening

SGMC Hosts Prostate Cancer Screening

Prostate most cancers is mainly the most typical most cancers among British men, with 47,000 diagnoses a twelve months.

If the cancer is at an early stage and not causing symptoms, a policy of "watchful waiting" or "active surveillance" may be adopted.

"We're seeing a lot of patients with prostate cancer who had a family history of the disease", Pendleton said. According to the American Cancer Society, prostate cancer begins when cells in the prostate gland start to grow out of control. Patients who get a positive result are usually given a biopsy which is also not foolproof.

Because prostate cancer can be asymptomatic in the early stages, getting screened after age 55 is key, but there are still signs to discuss with a urologist for further evaluation.

But these men still have a follow-up biopsy - where tissue is removed - unnecessarily, which risks bleeding and infection. By estimating unblemished living disease cells in the patient's blood, instead of the PSA protein which might be available in the blood for reasons other than malignancy, it possibly gives an increasingly exact test to prostate malignant growth.

A raised PSA level may suggest there is a problem with the prostate, but it does not necessarily mean cancer.

Another and straightforward blood test has been found to productively and precisely recognize the nearness of forceful prostate malignant growth, as indicated by research by Queen Mary University of London.

More news: Tropical Storm Humberto increases odds of development as it heads toward Florida
More news: England drop Jason Roy for final Ashes Test
More news: Pixel 4's Features Revealed In Latest Leaks

The exploration group found that the nearness of CTCs in pre-biopsy blood tests were demonstrative of the nearness of forceful prostate malignant growth, and effectively and non-obtrusively anticipated the later result of biopsy results.

"The good news is that prostate cancer is highly treatable when detected early", Dr. Brasfield said.

The PSA test now used in GP surgeries is unreliable, leading scientists to look for other methods, from MRI scans to blood tests, to more accurately diagnose them.

Professor Lu, from Queen Mary University of London, added: 'This causes significant harm to patients and a waste of valuable healthcare resources.

The study, in the Journal of Urology, looked at the use of the CTC test in 98 pre-biopsy patients and 155 newly diagnosed prostate cancer patients at St Bartholomew's Hospital in London. There is clearly a need for better selection of patients to undergo the biopsy procedure.

"We are discovering an extremely high rate of high-grade prostate cancer here in Routt and Summit counties", Pendleton said.

"Testing for circulating tumour cells is efficient, non-invasive and potentially accurate, and we've now demonstrated its potential to improve the current standard of care", he said.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.